Cargando…

(99m)tc-Ubiquicidin [29–41], a Promising Radiopharmaceutical to Differentiate Orthopedic Implant Infections from Sterile Inflammation

Ubiquicidin (UBI) [29-41] is a synthetic cationic antimicrobial peptide that preferentially binds to bacterial cell membrane at the site of infection. We aimed to assess diagnostic value of (99m)Tc-UBI [29-41] as a radiopharmaceutical in differentiation of bacterial infection from sterile inflammati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beiki, Davood, Yousefi, Gholamali, Fallahi, Babak, Tahmasebi, Mohammad Naghi, Gholamrezanezhad, Ali, Fard-Esfahani, Armaghan, Erfani, Mostafa, Eftekhari, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813225/ https://www.ncbi.nlm.nih.gov/pubmed/24250609

Ejemplares similares

Frequency and severity of myocardial perfusion abnormalities using Tc-99m MIBI SPECT in cardiac syndrome X
por: Saghari, Mohsen, et al.
Publicado: (2006)

Diagnostic Efficiency of (68)Ga-DOTATATE PET/CT as Compared to (99m)Tc-Octreotide SPECT/CT and Conventional Morphologic Modalities in Neuroendocrine Tumors
por: Fallahi, Babak, et al.
Publicado: (2019)

Successful application of technetium-99m-labeled octreotide acetate scintigraphy in the detection of ectopic adrenocorticotropin-producing bronchial carcinoid lung tumor: a case report
por: Esfahani, Armaghan Fard, et al.
Publicado: (2010)

A preliminary study of neuroSPECT evaluation of patients with post-traumatic smell impairment
por: Eftekhari, Mohammad, et al.
Publicado: (2005)

The Value of Technetium-99m Labeled Alpha-Melanocyte-Stimulating Hormone ((99m)Tc-α-MSH) in Diagnosis of Primary and Metastatic Lesions of Malignant Melanoma
por: Farzanefar, Saeed, et al.
Publicado: (2018)

Withholding or continuing beta-blocker treatment before dipyridamole myocardial perfusion imaging for the diagnosis of coronary artery disease? A randomized clinical trial
por: Fallahi, Babak, et al.
Publicado: (2013)

A (99m)Tc-tricine-HYNIC-labeled Peptide Targeting the Melanocortin-1 Receptor for Melanoma Imaging
por: Shamshirian, Danial, et al.
Publicado: (2016)

Assessment of prognostic value of semiquantitative parameters on gated single photon emission computed tomography myocardial perfusion scintigraphy in a large middle eastern population
por: Chavoshi, Maryam, et al.
Publicado: (2015)

Radiation-induced myocardial perfusion abnormalities in breast cancer patients following external beam radiation therapy
por: Eftekhari, Mohammad, et al.
Publicado: (2015)

Synthesis and Preliminary Evaluation of a New (99m)Tc Labeled Substance P Analogue as a Potential Tumor Imaging Agent
por: Mozaffari, Saeed, et al.
Publicado: (2015)

Diffuse pulmonary uptake of bone-seeking radiotracer in bone scintigraphy of a rare case of pulmonary alveolar microlithiasis
por: Fallahi, Babak, et al.
Publicado: (2015)

The present status of radiopharmaceuticals in the country
por: Jalilian, Amir Reza, et al.
Publicado: (2016)

(68)Ga-DOTATATE PET/CT Compared with (131)I-MIBG SPECT/CT in the Evaluation of Neural Crest Tumors
por: Shahrokhi, Pezhman, et al.
Publicado: (2020)

99m-Tc-ubiquicidin scintigraphy in diagnosis of knee prosthesis infection and comparison with F-18 fluorodeoxy-glucose positron emission tomography/computed tomography
por: Kamaleshwaran, Koramadai Karuppusamy, et al.
Publicado: (2015)

Non-Cutaneous Melanoma, Findings and Prognostic Value of FDG PET/CT: A Case Series of 23 patients and review of the literature
por: Saidi, Bahare, et al.
Publicado: (2022)

In Vitro Evaluation of Tc-99m Radiopharmaceuticals for Gastric Emptying Studies
por: Ertay, Türkan, et al.
Publicado: (2014)

Influence of Storage Temperature on Radiochemical Purity of (99m)Tc-Radiopharmaceuticals
por: Uccelli, Licia, et al.
Publicado: (2018)

Comparison of the Absorbed Dose for (99m)Tc-Diethylenetriaminepentaacetic Acid and (99m)Tc-Ethylenedicysteine Radiopharmaceuticals using Medical Internal Radiation Dosimetry
por: Pirdamooie, Shokufeh, et al.
Publicado: (2015)

Mathematical Simulation of Transport Kinetics of Tumor-Imaging Radiopharmaceutical (99m)Tc-MIBI
por: Shevtsova, O. N., et al.
Publicado: (2017)

Alternative chromatographic system for the quality control of lipophilic technetium-99m radiopharmaceuticals such as [(99m)Tc(MIBI)(6)](+)
por: Faria, D.P., et al.
Publicado: (2015)

Preclinical Evaluation of (68)Ga-MAA from Commercial Available (99m)Tc-MAA Kit
por: Shanehsazzadeh, Saeed, et al.
Publicado: (2017)

99mTechnetium-Ubiquicidin Scan with Single-Photon Emission Computed Tomography/Computed Tomography in Skull Base Osteomyelitis
por: Vatakara, Arunraj, et al.
Publicado: (2023)

Physicochemical and Biological Study of (99m)Tc and (68)Ga Radiolabelled Ciprofloxacin and Evaluation of [(99m)Tc]Tc-CIP as Potential Diagnostic Radiopharmaceutical for Diabetic Foot Syndrome Imaging
por: Koźmiński, Przemysław, et al.
Publicado: (2021)

Manifestations of Ollier's disease in a 21-year-old man: a case report
por: Fallahi, Babak, et al.
Publicado: (2009)

Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement
por: Miller, Edward J., et al.
Publicado: (2022)

Comparison of SPECT bone scintigraphy with MRI for diagnosis of meniscal tears
por: Tahmasebi, Mohammad-naghi, et al.
Publicado: (2005)

Radiation Levels from Toilets Used By Patients Injected with 99mTc-based Radiopharmaceuticals in Ibadan
por: Ejeh, John Enyi, et al.
Publicado: (2014)

Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of (99m)Tc-Tricarbonyl-Based Radiopharmaceuticals
por: Giammei, Carolina, et al.
Publicado: (2020)

Evaluation of [(99m)Tc][Tc-HYNIC/EDDA]-Tyr as a target for metabolic tumor imaging in B16F10 melanoma tumor
por: Yaghoubi Mogadam, Hemat, et al.
Publicado: (2022)

Common Shortcomings in Study on Radiopharmaceutical Design Research: A Case Study of (99m)Tc-Labelled Methotrexate
por: Koźmiński, Przemysław, et al.
Publicado: (2021)

(99m)Tc Glucarate as a Potential Radiopharmaceutical Agent for Assessment of Tumor Viability: From Bench to the Bed Side
por: Choudhury, Partha S., et al.
Publicado: (2012)

Estimating the Absorbed Dose of Organs in Pediatric Imaging of (99m)Tc-DTPATc-DTPA Radiopharmaceutical using MIRDOSE Software
por: K., Ebrahimnejad Gorji, et al.
Publicado: (2019)

Radiosynthesis, quality control, biodistribution, and infection-imaging study of a new (99m)Tc-labeled ertapenem radiopharmaceutical
por: Naqvi, Syed Ali Raza, et al.
Publicado: (2022)

Evaluation of (68)Ga-DOTA-Ubiquicidin (29–41) for imaging Staphylococcus aureus (Staph A) infection and turpentine-induced inflammation in a preclinical setting
por: Boddeti, Dilip Kumar, et al.
Publicado: (2021)

Evaluation of a (99m)Tc-tricine Vascular Disrupting Agent as an In-vivo Imaging in 4T1 Mouse Breast Tumor Model
por: Erfani, Mostafa, et al.
Publicado: (2017)

Dose-Dependent Internalization and Externalization Integrity Study of Newly Synthesized (99m)Tc-Thymoquinone Radiopharmaceutical as Cancer Theranostic Agent
por: Tariq, Saima, et al.
Publicado: (2020)

Quality Assessment of Tc-99m Methylene Diphosphonate (MDP) Radiopharmaceutical Prepared Using Different Cold Kit Fractionation Methods
por: Thokchom, Arun Kumar, et al.
Publicado: (2022)

Recombinant Complement Receptor 2 Radiolabeled with [(99m)Tc(CO)(3)](+) : A Potential New Radiopharmaceutical for Imaging Activated Complement
por: Badar, Adam, et al.
Publicado: (2011)

Synthesis and Biological Evaluation of Pyrazolo[1,5-a]-pyrimidine-containing (99m)Tc Nitrido Radiopharmaceuticals as Imaging Agents for Tumors
por: Ding, Rui, et al.
Publicado: (2010)

One-step, kit-based radiopharmaceuticals for molecular SPECT imaging: a versatile diphosphine chelator for (99m)Tc radiolabelling of peptides
por: Hungnes, Ingebjørg N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e797s3600f4jsl34i5h9ln9m0v